Patient info Open main menu

Monigen XL 60 – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: No longer supplied Details

Medicine strength:
60 mg
Still supplied:
The same active substance, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Contains active substance:

Patient leaflet - Monigen XL 60 prolonged-release tablets

1. What Monigen XL 60 is and what it is used for

Monigen XL 60 contains isosorbide mononitrate which belongs to a family of medicines known as nitrates. These medicines allow the blood vessels around the heart to relax and widen, allowing more blood to flow to the heart and around the body. Your medicine is in the form of a ‘prolonged release’ tablet, which slowly releases the medicine into your body.

Monigen XL 60 can be used to help prevent angina (a muscle cramp of the heart). However, Monigen XL 60 is not a suitable treatment for the relief of acute angina. If you suffer from an acute attack of angina, a more suitable medicine should be taken. Do not stop taking Monigen XL 60 without first consulting your doctor or pharmacist.

2. What you need to know before you take Monigen XL 60

Do not take Monigen XL 60:

  • if you are allergic to isosorbide mononitrate, other nitrates, or any of the other ingredients of this medicine (listed in section 6).
  • if you have heart conditions such as swelling of the lining that surrounds the heart, problems with your heart muscle or valves.
  • if you are taking sildenafil or similar medicines called “phosphodiesterase type-5 inhibitors” normally used to treat male impotence (erectile dysfunction).
  • If you are als taking ricociguat, see section “other medicines and Monigen XL”.
  • if you have very low blood pressure or problems with blood flow to the brain which may be due to blood pressure or blood vessel problems e.g. a stroke or a brain injury.
  • if you have a condition called “cardiogenic shock” which may occur after a heart attack when the body cannot pump enough blood around the body.

Warnings and precautions

Talk to your doctor or pharmacist before taking Monigen XL 60

  • if you have severe anaemia.
  • if you have hypothyroidism (underactive thyroid).
  • if you have raised pressure in the head (intra-cranial pressure).
  • if you have severe liver or kidney problems.
  • if you are malnourished or are unable to regulate body temperature (hypothermia) or develop these during treatment.
  • if you have hypoxaemia (low oxygen level in your blood, due to lung disease for example).

Other medicines and Monigen XL 60

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines including medicines obtained without a prescription. Do not take Monigen XL 60 with sildenafil or other phosphodiesterase type-5 inhibitors normally used to treat male impotence. If you take one of these medicines for erectile dysfunction, taking Monigen XL 60 as well can cause a severe and possibly dangerous fall in blood pressure. This could result in fainting, or even a heart attack.

Do not use Monigen XL at the same time as riocigaut since this can cause hypotension (abnormally low blood pressure).

If you are taking any of the following medicines it is important you talk to your doctor or pharmacist.

  • medicines for heart problems such as beta-blockers e.g. sotalol, carvedilol
  • diuretics, used to increase urination e.g. furosemide, hydrochlorothiazide
  • medicines for depression (called tricyclic antidepressants) e.g. mirtazapine, trimipramine
  • medicines used to treat anxiety and mental health conditions e.g. tranquillisers
  • alprostadil (a prostaglandin), another drug used for the treatment of male impotence
  • dihydroergotamine (used to treat migraines)
  • medicines that lower the blood pressure as their effect may become more pronounced (including vasodilators, antihypertensives, calcium channel blockers and angiotensin II receptor antagonists)
  • aldesleukin, a medicine used for the treatment of cancer

Monigen XL 60 with alcohol

Alcohol may increase the effect of reducing your blood pressure and may also make you drowsy. The use of alcohol should therefore be avoided.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Do not drive or operate machines if you feel dizzy or weak.

Monigen XL 60 contains lactose.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

3. How to take Monigen XL 60

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended starting dose is half a tablet (30 mg) a day for the first two to four days.

The tablet can be divided into equal doses.

After this, the recommended dose is one tablet (60 mg) a day, taken in the morning. When necessary the dose may be increased to two tablets (120 mg) a day, taken together in the morning.

Swallow the tablets with half a glass of water, in the morning.

Do not crush or chew the tablets, although you can divide them into equal doses if required.

During treatment

When you are taking this medicine, you may notice the remains of the tablet in your faeces. This is not a sign that this medicine is less effective. The medicine is released from the tablet leaving behind part of the tablet which you may pass in faeces.

Use in children and adolescents

Do not give these tablets to children and adolescents.

If you take more Monigen XL 60 than you should

The signs of an overdose may include headache, tiredness, flushing, feeling sick (nausea), vomiting, fast heart rate, diarrhoea, ‘spinning’ sensation or dizziness and fainting which may be due to low blood pressure. Large amounts of this medicine may cause a ‘blueing’ of the skin e.g. lips, or changes to breathing e.g. shortness of breath or slower breathing. If you suddenly experience any of the above, lie down with your legs raised slightly as this may help to ease the symptoms.

Contact your doctor or pharmacist immediately or go to the accident and emergency department of your local hospital at once. Take the carton or container of medicine with you, even if it is empty.

If you forget to take Monigen XL 60

Do not take a double dose to make up for a forgotten dose. If it is almost time for your next dose simply carry on as before.

If you stop taking Monigen XL 60

Do not stop taking these tablets without consulting your doctor or pharmacist as your chest pains may re-occur or get worse.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Side effects due to Monigen XL 60 are more likely to occur at the start of treatment.

If you experience any of the following, seek immediate medical attention:

  • signs of very low blood pressure such as:

    • pale, cold, clammy or blueish skin,
    • rapid, shallow breathing,
    • fast heart rate with dizziness,
    • a weak pulse,
    • confusion, anxiety or loss of consciousness.

These may be signs of circulatory collapse, a condition that can lead to an insufficient supply of oxygen to the brain, kidneys, skin, and other parts of the body. (Not known)

Other side effects

Very common (may affect more than 1 in 10 people)

  • headache

Common (may affect up to 1 in 10 people)

  • dizziness
  • feeling tired
  • low blood pressure
  • fast heart beat
  • feeling sick (nausea)

Uncommon (may affect up to 1 in 100 people)

  • flushing
  • vomiting
  • diarrhoea

Rare (may affect up to 1 in 1,000 people)

  • fainting
  • skin rash or itching

Very rare (may affect up to 1 in 10,000 people)

  • aching muscles, muscle tenderness or weakness, not caused by exercise (myalgia)

Not known (frequency cannot be estimated from the available data)

  • feeling sleepy
  • worsening of angina pectoris
  • slow heartbeat
  • low blood pressure causing dizziness when standing up
  • flaking or scaly skin, blisters
  • allergic skin reactions that may include bumps, redness and itching on your skin

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the internet at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Monigen XL 60

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the blister and the carton after “EXP”. The expiry date refers to the last day of that month.

Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Monigen XL 60 contains

  • Each tablet contains 60 mg of Isosorbide mononitrate.
  • The other ingredients are cellulose microcrystalline, kaolin heavy, magnesium stearate, silica colloidal anhydrous, synthetic paraffin wax and hard paraffin wax. The coating contains hypromellose, titanium dioxide (E171), lactose monohydrate (see section 2 ‘Monigen XL 60 contains lactose’), macrogol, iron oxide yellow (E172), iron oxide black (E172) and iron oxide red (E172)

What Monigen XL 60 looks like and contents of the pack

Monigen XL 60 are pale yellow, elliptical, film-coated tablets, marked with ‘IM’ breakline ‘60’ on one side and a break line on the reverse.

Monigen XL 60 are available in plastic containers with an optional plastic spacer at the top of the pack and blister packs of 7, 14, 28, 30, 60, 90, 98, 100, 100x1, 250 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

Manufacturers

Gerard Laboratories, 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13, Ireland

Mylan BV, Krijgsman 20, 1186DM Amstelveen, Netherlands

Mylan Hungary Kft., H-2900 Komárom, Mylan utca 1, Hungary

This leaflet was last revised in June 2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04569/0436

Last revision stated in the text: June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Monigen XL 60 prolonged-release tablets

Active substance Isosorbide mononitrate
Strength 60 mg
Pharmaceutical form Modified-release tablet
Pale yellow, elliptical, film-coated tablets (approximately 13.1 x 7.1 mm), embossed with ‘IM’ breakline ‘60’ on one side and breakline on the reverse
The tablet can be divided into equal doses.
How is it taken Oral
Excipients Cellulose microcrystalline, Kaolin, heavy, Magnesium stearate, Silica colloidal anhydrous, Paraffin wax, synthetic, Paraffin wax, hard, Hypromellose, Titanium dioxide (E171), Lactose monohydrate, Macrogol, Iron oxide, yellow (E172), Iron oxide, black (E172), Iron oxide, red (E172)
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Vasodilators used in cardiac diseases, organic nitrates
  1. C Cardiovascular system drugs
    1. C01 Cardiac therapy drugs
      1. C01D Vasodilators used in cardiac diseases
        1. C01DA Organic nitrates used in cardiac disease
          1. C01DA14 isosorbide mononitrate
Marketing authorisation PL 04569/0436 (first authorised 23 October 2008)
Marketing authorisation holder Generics [UK] Limited t/a Mylan
Codes BNF 02060100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.